BioSpring provides pre-clinical and commercial-scale oligonucleotide manufacturing capabilities for therapeutics use and preclinical mRNA capability. They support early-stage programs with small and intermediate-scale production and late-stage/commercial programs with cGMP manufacturing up to hundre...
BioSpring provides pre-clinical and commercial-scale oligonucleotide manufacturing capabilities for therapeutics use and preclinical mRNA capability. They support early-stage programs with small and intermediate-scale production and late-stage/commercial programs with cGMP manufacturing up to hundreds of kilograms of API quantities.
This website and its content are protected by international copyright laws. Unauthorized
use, reproduction, or distribution is prohibited.
We use essential cookies to make our platform work properly. With your consent, we also use limited
analytics cookies to understand site usage (e.g., number of visits). Without your consent, our default
cookie settings will apply.
Privacy Policy.
Alt-Fechenheim 34
Frankfurt, Main, 60386
Germany 
1
